These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 19217258

  • 1. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.
    Solari MG, Srinivasan S, Boumaza I, Unadkat J, Harb G, Garcia-Ocana A, Feili-Hariri M.
    J Autoimmun; 2009 Mar; 32(2):116-24. PubMed ID: 19217258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.
    Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, Remuzzi A, Benigni A.
    Transplant Proc; 2009 Jun; 41(5):1797-800. PubMed ID: 19545731
    [Abstract] [Full Text] [Related]

  • 4. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M.
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [Abstract] [Full Text] [Related]

  • 5. Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice.
    Ferrer-Garcia JC, Merino-Torres JF, Pérez Bermejo G, Herrera-Vela C, Ponce-Marco JL, Piñon-Selles F.
    Cell Transplant; 2003 Jun; 12(8):849-57. PubMed ID: 14763504
    [Abstract] [Full Text] [Related]

  • 6. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q, Wang D, Hadley GA, Farber DL, Bartlett ST.
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [Abstract] [Full Text] [Related]

  • 7. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
    Dufour JM, Lord SJ, Kin T, Rayat GR, Dixon DE, Bleackley RC, Korbutt GS, Rajotte RV.
    Cell Transplant; 2008 Aug; 16(10):1029-38. PubMed ID: 18351019
    [Abstract] [Full Text] [Related]

  • 8. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
    Emamaullee JA, Stanton L, Schur C, Shapiro AM.
    Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
    [Abstract] [Full Text] [Related]

  • 9. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S, Gunji T, Ise K, Sato Y, Saito T, Gotoh M.
    Transplantation; 2003 Jul 15; 76(1):65-71. PubMed ID: 12865788
    [Abstract] [Full Text] [Related]

  • 10. Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy.
    Machen J, Bertera S, Chang Y, Bottino R, Balamurugan AN, Robbins PD, Trucco M, Giannoukakis N.
    Gene Ther; 2004 Oct 15; 11(20):1506-14. PubMed ID: 15229635
    [Abstract] [Full Text] [Related]

  • 11. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB, Larsen PM, Fey S, Karlsen AE, Pociot F, Nerup J, Sparre T.
    Autoimmunity; 2006 Jun 15; 39(4):315-21. PubMed ID: 16891220
    [Abstract] [Full Text] [Related]

  • 12. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
    Sbano P, Cuccia A, Mazzanti B, Urbani S, Giusti B, Lapini I, Rossi L, Abbate R, Marseglia G, Nannetti G, Torricelli F, Miracco C, Bosi A, Fimiani M, Saccardi R.
    Arch Dermatol Res; 2008 Mar 15; 300(3):115-24. PubMed ID: 18259766
    [Abstract] [Full Text] [Related]

  • 13. Prolonged allogeneic islet graft survival by protoporphyrins.
    Pileggi A, Molano RD, Berney T, Ichii H, San Jose S, Zahr E, Poggioli R, Linetsky E, Ricordi C, Inverardi L.
    Cell Transplant; 2005 Mar 15; 14(2-3):85-96. PubMed ID: 15881418
    [Abstract] [Full Text] [Related]

  • 14. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S, Lin M, Zhang N, Teijaro JR, Stoica C, McEvoy R, Farber DL, Bona C, Brumeanu TD.
    Transplantation; 2008 Jun 27; 85(12):1717-25. PubMed ID: 18580462
    [Abstract] [Full Text] [Related]

  • 15. Would pancreas duct-epithelium-derived stem/progenitor cells enhance islet allograft survival by means of islets recruitment and tolerance induction in Edmonton protocol era?
    Chen B, Wang L, Hu S, Zhou L, Wang R, Wachtel MS, Frezza EE.
    Med Hypotheses; 2008 Jun 27; 70(3):661-4. PubMed ID: 17703891
    [Abstract] [Full Text] [Related]

  • 16. Prolonged local expression of anti-CD4 antibody by adenovirally transduced allografts can promote long-term graft survival.
    Londrigan SL, Sutherland RM, Brady JL, Zhan Y, Li R, Estella E, Kay TW, Lew AM.
    J Gene Med; 2006 Jan 27; 8(1):42-52. PubMed ID: 16075436
    [Abstract] [Full Text] [Related]

  • 17. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J, Sun J, Sung RS.
    Transpl Immunol; 2009 May 27; 21(1):33-42. PubMed ID: 19224710
    [Abstract] [Full Text] [Related]

  • 18. Gamma-irradiation as a tool to reduce immunogenicity of islet allo- and xenografts.
    Gotoh M, Kanai T, Dono K, Porter J, Maki T, Monaco AP.
    Horm Metab Res Suppl; 1990 May 27; 25():89-96. PubMed ID: 2088993
    [Abstract] [Full Text] [Related]

  • 19. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A, Saini D, Benshoff N, Goodman J, Desai NM, Chapman WC, Mohanakumar T.
    Transplantation; 2007 Nov 27; 84(10):1316-23. PubMed ID: 18049117
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.